Your doctor may recommend no treatment and regular monitoring if:
- Your calcium levels are only slightly elevated
- Your kidneys are functioning normally, and you have no kidney stones
- Your bone density is normal or only slightly below normal
- You have no other symptoms that may improve with treatment
If you choose this watch-and-wait approach, you'll likely need periodically scheduled tests to monitor your blood-calcium levels and bone density.
Surgery is the most common treatment for primary hyperparathyroidism and provides a cure in about 95 percent of all cases. A surgeon will remove only those glands that are enlarged or have a tumor (adenoma).
If all four glands are affected, a surgeon will likely remove only three glands and perhaps a portion of the fourth — leaving some functioning parathyroid tissue.
Surgery may be done as an outpatient procedure, allowing you to go home the same day. In such cases, the surgery can be done through very small incisions in the neck, and you receive only local anesthetics.
Complications from surgery aren't common. Risks include:
- Damage to nerves controlling the vocal cords
- Long-term low calcium levels requiring the use of calcium and vitamin D supplements
Medications to treat hyperparathyroidism include the following:
Dec. 24, 2015
Calcimimetics. A calcimimetic is a drug that mimics calcium circulating in the blood. The drug may trick the parathyroid glands into releasing less parathyroid hormone. This drug is sold as cinacalcet (Sensipar).
The Food and Drug Administration approved cinacalcet to treat hyperparathyroidism caused by chronic kidney disease or parathyroid cancer. Some doctors may prescribe it to treat primary hyperparathyroidism, particularly if surgery hasn't successfully cured the disorder or a person isn't a good candidate for surgery.
The most commonly reported side effects of cinacalcet are joint and muscle pain, diarrhea, nausea, and respiratory infection.
Hormone replacement therapy. For women who have gone through menopause and have signs of osteoporosis, hormone replacement therapy may help bones retain calcium. This treatment doesn't address the underlying problems with the parathyroid glands.
Prolonged use of hormone replacement therapy can increase the risk of blood clots and breast cancer. Work with your doctor to evaluate the risks and benefits to help you decide what's best for you.
Some common side effects of hormone replacement therapy include breast pain and tenderness, dizziness, and headache.
- Bisphosphonates. Bisphosphonates also prevent the loss of calcium from bones and may lessen osteoporosis caused by hyperparathyroidism. Some side effects associated with bisphosphonates include low blood pressure, fever and vomiting.
- Primary hyperparathyroidism. National Endocrine and Metabolic Diseases Information Service. http://endocrine.niddk.nih.gov/pubs/hyper/. Accessed Feb. 15, 2014.
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Feb. 15, 2014.
- El-Hajj Fuleihan G. Pathogenesis and etiology of primary hyperthyroidism. http://www.uptodate.com/home. Accessed Feb. 15, 2014.
- Papadakis MA, et al. Current Medical Diagnosis & Treatment 2014. 53rd ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=1. Accessed Feb. 15, 2014.
- Bilezikian JP, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the third international workshop. Journal of Clinical Endocrinology and Metabolism. 2009;94:335.
- Hormone replacement therapy. Micromedex 2.0 Healthcare Series. http://www.micromedexsolutions.com. Accessed Feb. 15, 2014.
- Vitamin D: Fact sheet for consumers. Office of Dietary Supplements. http://ods.od.nih.gov/factsheets/VitaminD-QuickFacts. Accessed Feb. 15, 2014.
- Calcium: Fact sheet for consumers. Office of Dietary Supplements. http://ods.od.nih.gov/factsheets/Calcium-QuickFacts. Accessed Feb. 15, 2014.
- Smoking and bone health. NIH Osteoporosis and Related Bone Diseases — National Resource Center. http://www.niams.nih.gov/Health_Info/Bone/Osteoporosis/Conditions_Behaviors/bone_smoking.asp. Accessed Feb. 15, 2014.
- Korkmaz HA, et al. Neonatal seizure as a manifestation of unrecognized maternal hyperparathyroidism. Journal of Clinical Research in Pediatric Endocrinology. 2013;5:206.
- Nippoldt TB (expert opinion). Mayo Clinic, Rochester, Minn. Feb. 28, 2014.